# OnCo record tumour-informed-assay (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/tumour-informed-assay/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "tumour-informed-assay" ;
  schema:name "Tumour-informed versus tumour-naive ctDNA assays"@en ;
  schema:alternateName "Tumour-informed MRD"@en, "Tumour-agnostic ctDNA assay"@en, "Personalised ctDNA panel"@en ;
  schema:description "A tumour-informed blood test is built for one patient: the tumour is sequenced first and the test then hunts for that patient's own mutations in blood. A tumour-naive test uses the same fixed panel, often of methylation marks, for everyone, so it needs no tumour sample and returns faster."@en ;
  schema:url <https://onco.cc/terms/tumour-informed-assay/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://europepmc.org/article/MED/41124204>, <https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleId=58456> ;
  onco:related <https://onco.cc/roadmaps/ctdna-tests/>, <https://onco.cc/trials/imvigor011/>, <https://onco.cc/trials/dynamic/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/mced/>, <https://onco.cc/technologies/cfdna-methylation-testing/> ;
  onco:drugs <https://onco.cc/drugs/signatera/>, <https://onco.cc/drugs/radar-mrd/>, <https://onco.cc/drugs/guardant-reveal/>, <https://onco.cc/drugs/galleri/> ;
  onco:terms <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/cfdna/>, <https://onco.cc/pathways/clonal-haematopoiesis/> .